title: Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
authors.affiliation: Department of Oncology, Military Institute of Health, Warsaw, Poland. s.szmit@gmail.com
authors.forename: Sebastian
authors.initials: S
authors.lastname: Szmit
authors.forename: Pawel
authors.initials: P
authors.lastname: Nurzyński
authors.forename: Norbert
authors.initials: N
authors.lastname: Szaluś
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Opolski
authors.forename: Cezary
authors.initials: C
authors.lastname: Szczylik
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001794:Blood Pressure; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D015637:Gated Blood-Pool Imaging; D006333:Heart Failure / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008207:Lymphatic Metastasis; D008790:Metoprolol / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D000077210:Sunitinib; D016896:Treatment Outcome; D014336:Troponin / Q000097:blood
chemical_list: D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents; D004232:Diuretics; D007211:Indoles; D011758:Pyrroles; D014336:Troponin; D005665:Furosemide; D008790:Metoprolol; D000077210:Sunitinib